Lowering PSA cutoffs to enhance detection of curable prostate cancer (original) (raw)
Is Prostate Biopsy Recommended In Men With a PSA Between 2,5 - 4 ng/mL?
hakan türk
Current Therapeutic Research, 2017
View PDFchevron_right
Prostate cancer incidence and diagnosis in men with PSA levels >20 ng/ml: is it possible to decrease the number of biopsy cores?
sefa alperen öztürk
The Aging Male, 2019
View PDFchevron_right
PSA and the Detection of Prostate Cancer After 2005. Part I
Renske Postma
EAU-EBU Update Series, 2006
View PDFchevron_right
Use and Assessment of PSA in Prostate Cancer
Carl Gjertson
Medical Clinics of North America, 2011
View PDFchevron_right
Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or Lower
Scott Lucia
JAMA, 2005
View PDFchevron_right
Predictive criteria for prostate cancer detection in men with serum PSA concentration of 2.0 to 4.0 ng/mL
sergey kravchick
Urology, 2005
View PDFchevron_right
The effect of percentage free prostate-specific antigen (PSA) level on the prostate cancer detection rate in a screening population with low PSA levels
Peter Rehder
BJU International, 2005
View PDFchevron_right
PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL
Alexandre Zlotta
Urology, 1999
View PDFchevron_right
Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL
LUcas Nogueira
BJU International, 2012
View PDFchevron_right
Does PSA Velocity Predict Prostate Cancer in Pre-Screened Populations?
Theodorus Van Der Kwast
European Urology, 2006
View PDFchevron_right
The Utility of PSA and PSA Density in Assessing the Risk of Prostate Cancer
IOSR Journals
View PDFchevron_right
Contribution of a Single Repeat PSA Test to Prostate Cancer Risk Assessment: Experience from the ProtecT Study
Derek J Rosario
European Urology, 2008
View PDFchevron_right
Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50�years
Cary N Robertson MD FACS, David Albala
BJU International, 2007
View PDFchevron_right
Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years
David Albala
BJUI, 2007
View PDFchevron_right
Usefulness of the ratio free/total prostatespecific antigen in addition to total PSA levels in prostate cancer screening
Helmut Klocker
Urology, 1996
View PDFchevron_right
Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/ml
Emerson Pereira
International Braz J Urol, 2007
View PDFchevron_right
Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL ORIGINAL RESEARCH
Mireille Gregoire
Canadian Urological Association Journal Journal De L Association Des Urologues Du Canada, 2007
View PDFchevron_right
Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics
Robert Veltri
Urology, 2001
View PDFchevron_right
PSA density as a better predictor of prostate cancer than percent-free PSA in a repeat biopsy
Chen-li Cheng, Chi-Rei Yang
Journal of the Chinese Medical Association, 2011
View PDFchevron_right
Prostate cancer screening and the role of PSA: A UK perspective
Prasanna Sooriakumaran
Cleveland Clinic Journal of Medicine, 2020
View PDFchevron_right
Prostate Cancer in Patients With Screening Serum Prostate Specific Antigen Values Less Than 4.0 NG/DL: Results From the Cooperative Prostate Cancer Tissue Resource
Jules Berman, Michael Becich
The Journal of Urology, 2005
View PDFchevron_right
Intermediate-term Risk of Prostate Cancer is Directly Related to Baseline PSA: Implications for Reducing the Burden of PSA Screening
Javier Hernandez
The Journal of Urology, 2015
View PDFchevron_right
Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or Lower—Correction
Howard Parnes
JAMA, 2006
View PDFchevron_right